Cart
sales@molnova.com
Cyclophosphamide
CAS No. 50-18-0
Cyclophosphamide ( —— )
Catalog No. M14690 CAS No. 50-18-0
A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities; used to treat cancers and autoimmune diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 32 | In Stock |
|
| 100MG | 46 | In Stock |
|
| 200MG | 64 | In Stock |
|
| 500MG | 128 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCyclophosphamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionA synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities; used to treat cancers and autoimmune diseases.
-
DescriptionA synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities; used to treat cancers and autoimmune diseases.Chemotherapeutic Agents Approved
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetDNA Alkylator
-
RecptorDNA Alkylator
-
Research AreaCancer
-
IndicationChemotherapeutic
Chemical Information
-
CAS Number50-18-0
-
Formula Weight261.09
-
Molecular FormulaC7H15Cl2N2O2P
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 38 mg/mL
-
SMILESC1CNP(=O)(OC1)N(CCCl)CCCl
-
Chemical Name2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Quinacrine dihydroch...
An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years.
-
Dicycloplatin
Dicycloplatin (DCP) is a novel platinum analog that demonstrates significant antitumor activity against a variety of human cancer cell lines with IC50 of 25-30 nM.
-
Glufosfamide
A conjugate of glucose and active alkylating moiety of ifosfamide with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters.
